Project Flyer Project Flyer

Click here to download the project flyer Cardiorisk.


Consortium Consortium
 CARDIORISK Consortium

QuicklinksQuicklinks
Main Focus Main Focus
The Project The Project
Impact Impact


LoginMembers
Login Login



SEVENTH FRAMEWORK PROGRAMME

The Group - Consortium - The Netherlands Cancer Institute

Logo NKI

The Netherlands Cancer Institute

Division of Experimental Therapy
Plesmanlaan 121
1066 CX Amsterdam

The Netherlands


 Homepage



Project Leader


Dr. Fiona Stewart Dr. Fiona Stewart
Phone: +31205122036 
Fax: +31205122050 
E-Mail to Dr. Fiona Stewart Contact  



Project Staff


Mr. Nils Visser
Technician / mouse irradiation and imaging,  tissue preparation, immunohistochemistry 
Phone: +31205122043 
Fax: +31205122050 
E-Mail to Mr. Nils Visser Contact  

Dr. Saske Hoving
Post doc / general supervision<BR> 
Phone: +31205122043 
Fax: +31205122050 
E-Mail to Dr. Saske Hoving Contact  

Dr. Hans Te Poele
Chief technician / mouse irradiation, imaging mice 
Phone: +31205122043 
Fax: +31205122050 
E-Mail to Dr. Hans Te Poele Contact  


Institute Presentation


The Netherlands Cancer Institute (NKI-AVL) consists of an integrated cancer hospital with 13 research divisions for fundamental and applied cancer research. The Department of Radiotherapy treats 3500 new patients a year, including over 1000 with breast cancer. Many of these patients are enrolled in clinical trials. The Radiotherapy and Epidemiology departments have evaluated the level of increased risk and dose response effect for second tumors and cardio-vascular events following treatment for Hodgkin's disease, non- Hodgkin's lymphoma, testicular cancer and breast cancer. The radiotherapy and nuclear medicine departments are now prospectively following changes in heart function in breast cancer patients treated with combined radiotherapy and systemic chemotherapy or trastuzumab (Herceptin).

Research support facilities include biometrics, with a comprehensive patient and tumor registration, a laboratory animal department with pathology and transgenic mouse services, a microarray facility and confocal, FACS and digital analysis facilities. A mouse cancer clinic has been set up with dedicated irradiation facilities and scanners for mice (e.g. SPECT/CT, x-ray mammography).

Dr Fiona Stewart runs the normal tissue radiation biology program in the Division of Experimental Therapy at the NKI. This research program uses patient material, animal models and in vitro models to study underlying mechanisms of normal tissue damage after radiotherapy, with the focus on vascular damage. The group has extensive skills in local irradiation of small animals and in vivo testing of functional changes, and in quantitative immunohistochemistry. Dr Stewart has ongoing collaborations with Prof. Mat Daemen and Dr Sylvia Heeneman (CARIM, University of Maastricht) to study mechanisms of radiation induced atherosclerosis, and with Prof. Peter ten Dijke and Prof. Christine Mummery (Leiden University Medical Center) to investigate the molecular mechanisms of radiation induced telangiectasia, and radiation induced cardiovascular damage.


The Netherlands Cancer Institute